CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 11,270,000 shares, an increase of 39.5% from the May 15th total of 8,080,000 shares. Based on an average trading volume of 5,510,000 shares, the short-interest ratio is […]
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) was the target of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 11,270,000 shares, an increase of 39.5% from the May 15th total of 8,080,000 shares. Based on an average daily trading volume, of 5,510,000 shares, […]
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating)’s stock price hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $9.08 and last traded at $9.08, with a volume of 202576 shares changing hands. The stock had previously closed at $9.07. Analyst Ratings Changes Several brokerages recently issued reports […]
Equities Research Analysts’ new coverage for Saturday, June 3rd: StockNews.com began coverage on shares of Aptevo Therapeutics (NASDAQ:APVO). They issued a hold rating on the stock. StockNews.com started coverage on shares of Avinger (NASDAQ:AVGR). They issued a sell rating on the stock. StockNews.com assumed coverage on shares of Azure Power Global (NYSE:AZRE). They issued a […]
CTI BioPharma (NASDAQ: CTIC) recently received a number of ratings updates from brokerages and research firms: 5/26/2023 – CTI BioPharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/18/2023 – CTI BioPharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/16/2023 […]